| Product Code: ETC7647454 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cardiovascular Genetic Testing Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cardiovascular Genetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cardiovascular Genetic Testing Market - Industry Life Cycle |
3.4 Israel Cardiovascular Genetic Testing Market - Porter's Five Forces |
3.5 Israel Cardiovascular Genetic Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 Israel Cardiovascular Genetic Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Israel Cardiovascular Genetic Testing Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.8 Israel Cardiovascular Genetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Cardiovascular Genetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Israel |
4.2.2 Growing awareness about the benefits of genetic testing for cardiovascular health |
4.2.3 Technological advancements leading to more accurate and cost-effective genetic testing solutions |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for genetic testing in Israel |
4.3.2 Regulatory challenges and complexities associated with genetic testing |
4.3.3 Lack of trained healthcare professionals for interpreting genetic testing results |
5 Israel Cardiovascular Genetic Testing Market Trends |
6 Israel Cardiovascular Genetic Testing Market, By Types |
6.1 Israel Cardiovascular Genetic Testing Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Inherited Cardiomyopathies, 2021- 2031F |
6.1.4 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Hypertrophic Cardiomyopathy (HCM), 2021- 2031F |
6.1.5 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Dilated Cardiomyopathy (DCM), 2021- 2031F |
6.1.6 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Arrhythmia, 2021- 2031F |
6.1.7 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Aortopathies, 2021- 2031F |
6.1.8 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Cardiovascular Genetic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Cytogenetic Testing, 2021- 2031F |
6.2.3 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Biochemical Testing, 2021- 2031F |
6.2.4 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Molecular Testing, 2021- 2031F |
6.3 Israel Cardiovascular Genetic Testing Market, By Testing Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Predictive Testing, 2021- 2031F |
6.3.3 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Carrier Testing, 2021- 2031F |
6.3.4 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Prenatal and Newborn Testing, 2021- 2031F |
6.3.5 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Diagnostic Testing, 2021- 2031F |
6.3.6 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Pharmacogenomic Testing, 2021- 2031F |
6.3.7 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Cardiovascular Genetic Testing Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Chromosome Analysis, 2021- 2031F |
6.4.3 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Genetic Disease Diagnosis, 2021- 2031F |
6.4.4 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Cardiovascular Disease Diagnosis, 2021- 2031F |
6.4.5 Israel Cardiovascular Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Cardiovascular Genetic Testing Market Import-Export Trade Statistics |
7.1 Israel Cardiovascular Genetic Testing Market Export to Major Countries |
7.2 Israel Cardiovascular Genetic Testing Market Imports from Major Countries |
8 Israel Cardiovascular Genetic Testing Market Key Performance Indicators |
8.1 Adoption rate of genetic testing for cardiovascular diseases in Israel |
8.2 Number of research studies and publications supporting the efficacy of cardiovascular genetic testing |
8.3 Rate of integration of genetic testing into standard cardiovascular care protocols |
9 Israel Cardiovascular Genetic Testing Market - Opportunity Assessment |
9.1 Israel Cardiovascular Genetic Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 Israel Cardiovascular Genetic Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Israel Cardiovascular Genetic Testing Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
9.4 Israel Cardiovascular Genetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Cardiovascular Genetic Testing Market - Competitive Landscape |
10.1 Israel Cardiovascular Genetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Israel Cardiovascular Genetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here